Difficulties in Establishing the Adverse Effects of β-Casomorphin-7 Released from β-Casein Variants-A Review.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Difficulties in Establishing the Adverse Effects of β-Casomorphin-7 Released from β-Casein Variants-A Review.
- Published In:
- Foods (Basel, Switzerland), 12(17) (2023)
- Authors:
- de Vasconcelos, Marta Liliane, Oliveira, Luisa Maria F S, Hill, Jeremy Paul, Vidal, Ana Maria Centola
- Database ID:
- RPEP-06831
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06831APA
de Vasconcelos, Marta Liliane; Oliveira, Luisa Maria F S; Hill, Jeremy Paul; Vidal, Ana Maria Centola. (2023). Difficulties in Establishing the Adverse Effects of β-Casomorphin-7 Released from β-Casein Variants-A Review.. Foods (Basel, Switzerland), 12(17). https://doi.org/10.3390/foods12173151
MLA
de Vasconcelos, Marta Liliane, et al. "Difficulties in Establishing the Adverse Effects of β-Casomorphin-7 Released from β-Casein Variants-A Review.." Foods (Basel, 2023. https://doi.org/10.3390/foods12173151
RethinkPeptides
RethinkPeptides Research Database. "Difficulties in Establishing the Adverse Effects of β-Casomo..." RPEP-06831. Retrieved from https://rethinkpeptides.com/research/de-2023-difficulties-in-establishing-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.